Home Business Health AstraZeneca To Invest $1.5b To Manufacture Cancer Killer In Singapore
Health

AstraZeneca To Invest $1.5b To Manufacture Cancer Killer In Singapore

Share
Share

AstraZeneca says it  will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs).

The biopharmaceutical giant announced on Monday.

AstraZeneca aimed to start designing and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029.

According to the company ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

IWD 2025: Leadway Health HMO Champions Women’s Health

In recognition of International Women’s Month this March, Leadway Health HMO has...

Tinubu Grants Automatic Employment To 774 Health Fellows

President Bola Tinubu on Thursday granted automatic employment to 774 fellows of...

Lagos Records 900,000 Cases Of Malaria Annually-  Commissioner

The Lagos State  Commissioner for Health, Prof. Akin Abayomi, on Tuesday said...

13 US Patients Receive Kidney Transplant In Nigeria- VP Shettima

Vice President Kashim Shettima has observed that Nigeria is witnessing a surge...